The frequency of a new tick-borne infection that shares many similarities with Lyme disease, and a description of the antibody test used to test individuals for evidence of the infection, have been reported for the first time by researchers at the Yale Schools of Public Health and Medicine.
When you get sick, your physician may take a sample of your blood, send it to the laboratory and wait for results. In the near future, however, doctors may be able to run those tests almost instantly on a piece of plastic about the size of credit card. These labs-on-a-chip would not only be quick—results are available in minutes—but also inexpensive and portable.
When someone suffers from a stroke, a silent countdown begins. A fast diagnosis and treatment can mean the difference between life and death. So scientists are working on a new blood test that one day could rapidly confirm whether someone is having a stroke and what kind.
A research team using tunable luminescent nanocrystals as tags to advance medical and security imaging have successfully applied them to high-speed scanning technology and detected multiple viruses within minutes. The research builds on the team's earlier success in developing a way to control the length of time light from a luminescent nanocrystal lingers.
Federal health regulators have cleared a genetic test from Roche as the first ever U.S.-approved alternative to the Pap smear, the decades-old mainstay of cervical cancer screening. The U.S. Food and Drug Administration approved Swiss-based Roche's cobas HPV test to detect the human Papillomavirus, or HPV, in women 25 and up. HPV causes nearly all cases of cervical cancer.
A team at Purdue Univ. has used gold nanoparticles to target and bind to fragments of genetic material known as BRCA1 messenger RNA splice variants, which can indicate the presence and stage of breast cancer. The number of these synthetic DNA “tails” in a cell can be determined in a living cell by examining the specific signal that light produces when it interacts with the gold nanoparticles.
Unlike healthy cells, cancer cells thrive when deprived of oxygen. Tumors in low-oxygen environments tend to be more resistant to therapy and spread more aggressively to other parts of the body. Measuring tumors’ oxygen levels could help doctors make decisions about treatments, but there’s currently no way to make such measurements. However, a new sensor developed at Massachusetts Institute of Technology could change that.
A credit-card-sized anthrax detection cartridge developed at Sandia National Laboratories and recently licensed to a small business makes testing safer, easier, faster and cheaper. Bacillus anthracis, the bacteria that causes anthrax, is commonly found in soils all over the world and can cause serious, and often fatal, illness in both humans and animals.
Researchers have discovered that the so-called HOPE method allows tissue samples to be treated such that they do not only meet the requirements of clinical histology, but can still be characterized later on by modern methods of proteomics, a technique that analyzes all proteins at once. This differs from the traditional formalin-based approach that cross-links protein molecules.
In the fictional Star-Trek universe, the tricorder was used to remotely scan patients for a diagnosis. A new device under development in the U.K. could perform that function through the use of chemical sensors on printed circuit boards. This would replace the current conventional diagnostic method, which is lengthy and is limited to single point measurements.
Call it “homo minutus”. A team at Los Alamos National Laboratory is developing four human organ constructs (liver, heart, lung and kidney) that will work together to serve as a drug and toxicity analysis system that can mimic the actual response of human organs. Called ATHENA, for Advanced Tissue-engineered Human Ectypal Network Analyzer, the system will fit neatly on a desk.
A new microfluidic method for evaluating drugs commonly used for preventing heart attacks has found that while aspirin can prevent dangerous blood clots in some at-risk patients, it may not be effective in all patients with narrowed arteries. The study, a first in the examination of heart attack prevention drugs, used a device that simulated blood flowing through narrowed coronary arteries to assess effects of anti-clotting drugs.
It's a jungle in there. In the tightly woven ecosystem of the human gut, trillions of bacteria compete with each other on a daily basis while they sense and react to signals from the immune system, ingested food and other bacteria. Problems arise when bad gut bugs overtake friendly ones, or when the immune system is thrown off balance.
Smartphones are capable of giving us directions when we’re lost, sending photos and videos to our friends in mere seconds and, perhaps very soon, diagnose our diseases in real time. Researchers in Texas are developing a disease diagnostic system made of a glass slide and a porous film of gold that offers results that could be read using only a smartphone and a $20 lens attachment.
Ever since the study of individual genes and RNAs was first known to be important, there has been a drive to get as detailed and complete genomic information as possible. Early technologies like the hybridization-based Southern and Northern blotting methods were tremendous advances, but allowed only a handful of genomic targets to be studied at a time.
When a person becomes sick or is exposed to an unwelcome substance, the body mobilizes specific proportions of different immune cells in the blood. Methods of discovering and detecting those profiles are therefore useful both clinically and in research. In a new Genome Biology paper, a team of scientists describes a new and uniquely advantageous way to detect them.
About the size of a stapler, this new handheld device developed in Switzerland is able to test a large number of proteins in our body all at once. This optical “lab on a chip” is compact and inexpensive, and it could offer the possibility of quickly analyzing up to 170,000 different molecules in a blood sample.
Finding treatments for advanced stage cancer isn’t easy. Therefore, early detection methods are paramount in the fight against the disease. Motivated by the opportunity to intervene as early as possible in the course of cancer, Dr. Muneesh Tewari, a Univ. of Michigan researcher, has been studying the diagnostic potential of blood-based biomarkers.
Before doctors like Matthias Kretzler can begin using the results of molecular research to treat patients, they need science to find an effective way to match genes with the specific cells involved in disease. As Kretzler explains, finding that link would eventually let physicians create far more effective diagnostic tools and treatments.
From the sun, a solution: Cornell Univ. and Weill Cornell Medical College researchers have remodeled an energy-intensive medical test, designed to detect a deadly skin cancer related to HIV infections, to create a quick diagnostic assay perfect for remote regions of the world. By harnessing the sun’s power and employing a smartphone application, medical technicians may now handily administer reliable assays for Kaposi’s sarcoma.
Purdue Univ. researchers have developed a laser sensor that can identify Salmonella bacteria grown from food samples about three times faster than conventional detection methods. Known as BARDOT, the machine scans bacteria colonies and generates a distinct black and white "fingerprint" by which they can be identified. BARDOT takes less than 24 hrs to pinpoint Salmonella.
A one-letter change in the human genetic code can sometimes mean the difference between health and a serious disease. But replicating these tiny changes in human stem cells has proven challenging. Scientists at the Gladstone Institutes have found a way to efficiently edit the human genome one letter at a time, not only boosting researchers' ability to model human disease, but also paving the way for new therapies.
Pancreatic cancer is a particularly devastating disease. At least 94% of patients will die within five years, and in 2013 it was ranked as one of the top 10 deadliest cancers. Routine screenings for breast, colon and lung cancers have improved treatment and outcomes for patients with these diseases. But because little is known about how pancreatic cancer behaves, patients often receive a diagnosis when it’s already too late.
Progress often requires change. For protein-based diagnostics, multiplexed assays and detection of protein isoforms will drive the adoption of a new strategy for diagnostic testing, called immuno-MS. Enzyme-linked immunosorbent assays (ELISA) have become the standard for antibody-based diagnostic tests in clinical settings. ELISAs provide specific detection of biomarkers through use of antibodies which target specific epitopes on antigens.
Medical laboratory test results provide physicians with vital information needed for accurate diagnosis, treatment and monitoring of patients. An estimated 60 to 70% of all decisions regarding a patient’s diagnosis and treatment, hospital admission and discharge are based on laboratory test results.